Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life.

Hser YI, Mooney LJ, Huang D, Zhu Y, Tomko RL, McClure E, Chou CP, Gray KM.

J Subst Abuse Treat. 2017 Oct;81:53-58. doi: 10.1016/j.jsat.2017.07.012. Epub 2017 Jul 29.

PMID:
28847455
2.

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR.

Drug Alcohol Depend. 2017 Aug 1;177:249-257. doi: 10.1016/j.drugalcdep.2017.04.020. Epub 2017 Jun 10.

PMID:
28623823
3.

Chronic pain among patients with opioid use disorder: Results from electronic health records data.

Hser YI, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Huang D.

J Subst Abuse Treat. 2017 Jun;77:26-30. doi: 10.1016/j.jsat.2017.03.006. Epub 2017 Mar 9.

PMID:
28476267
4.

High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System.

Hser YI, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Zhu Y, Liang D, Huang D.

J Addict Med. 2017 Jul/Aug;11(4):315-319. doi: 10.1097/ADM.0000000000000312.

PMID:
28426439
5.

Mindfulness Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial.

Glasner-Edwards S, Mooney LJ, Ang A, Garneau HC, Hartwell E, Brecht ML, Rawson RA.

Mindfulness (N Y). 2017 Feb;8(1):126-135. doi: 10.1007/s12671-016-0586-9. Epub 2016 Aug 4.

PMID:
28191264
6.

Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.

Mooney LJ, Hillhouse MP, Thomas C, Ang A, Sharma G, Terry G, Chang L, Walker R, Trivedi M, Croteau D, Sparenborg S, Ling W.

J Addict Med. 2016 Jul-Aug;10(4):236-43. doi: 10.1097/ADM.0000000000000218.

7.

Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.

Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J.

Addiction. 2016 Aug;111(8):1416-27. doi: 10.1111/add.13375. Epub 2016 Apr 21.

8.

Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.

Robertson CL, Ishibashi K, Chudzynski J, Mooney LJ, Rawson RA, Dolezal BA, Cooper CB, Brown AK, Mandelkern MA, London ED.

Neuropsychopharmacology. 2016 May;41(6):1629-36. doi: 10.1038/npp.2015.331. Epub 2015 Oct 27.

9.

Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories.

Jacobs P, Ang A, Hillhouse MP, Saxon AJ, Nielsen S, Wakim PG, Mai BE, Mooney LJ, S Potter J, Blaine JD.

Am J Addict. 2015 Oct;24(7):667-75. doi: 10.1111/ajad.12288. Epub 2015 Sep 24.

10.

Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care.

Rawson RA, Chudzynski J, Mooney L, Gonzales R, Ang A, Dickerson D, Penate J, Salem BA, Dolezal B, Cooper CB.

Drug Alcohol Depend. 2015 Nov 1;156:21-28. doi: 10.1016/j.drugalcdep.2015.08.029. Epub 2015 Sep 3.

11.

The Impact of Exercise On Depression and Anxiety Symptoms Among Abstinent Methamphetamine-Dependent Individuals in A Residential Treatment Setting.

Rawson RA, Chudzynski J, Gonzales R, Mooney L, Dickerson D, Ang A, Dolezal B, Cooper CB.

J Subst Abuse Treat. 2015 Oct;57:36-40. doi: 10.1016/j.jsat.2015.04.007. Epub 2015 Apr 15.

12.

Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention.

Haglund M, Ang A, Mooney L, Gonzales R, Chudzynski J, Cooper CB, Dolezal BA, Gitlin M, Rawson RA.

Am J Addict. 2015 Apr;24(3):246-51. doi: 10.1111/ajad.12175.

PMID:
25907813
13.

Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention.

Haglund M, Ang A, Mooney L, Gonzales R, Chudzynski J, Cooper CB, Dolezal BA, Gitlin M, Rawson RA.

Am J Addict. 2014 Dec 11. doi: 10.1111/j.1521-0391.2014.12175.x. [Epub ahead of print]

PMID:
25496501
14.

Methamphetamine psychosis: epidemiology and management.

Glasner-Edwards S, Mooney LJ.

CNS Drugs. 2014 Dec;28(12):1115-26. doi: 10.1007/s40263-014-0209-8. Review.

15.

Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.

McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, Haynes L, Brigham GS, Sparenborg S, Hasson AL, Gray KM.

Contemp Clin Trials. 2014 Nov;39(2):211-23. doi: 10.1016/j.cct.2014.08.011. Epub 2014 Aug 30.

16.

Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users.

Nielsen S, Hillhouse M, Mooney L, Ang A, Ling W.

J Subst Abuse Treat. 2015 Jan;48(1):70-6. doi: 10.1016/j.jsat.2014.06.006. Epub 2014 Jun 28.

17.

Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.

Ling W, Chang L, Hillhouse M, Ang A, Striebel J, Jenkins J, Hernandez J, Olaer M, Mooney L, Reed S, Fukaya E, Kogachi S, Alicata D, Holmes N, Esagoff A.

Addiction. 2014 Sep;109(9):1489-500. doi: 10.1111/add.12608. Epub 2014 Jul 8.

18.

Exercise for methamphetamine dependence: rationale, design, and methodology.

Mooney LJ, Cooper C, London ED, Chudzynski J, Dolezal B, Dickerson D, Brecht ML, Peñate J, Rawson RA.

Contemp Clin Trials. 2014 Jan;37(1):139-47. doi: 10.1016/j.cct.2013.11.010. Epub 2013 Nov 28.

19.

Exercise training improves heart rate variability after methamphetamine dependency.

Dolezal BA, Chudzynski J, Dickerson D, Mooney L, Rawson RA, Garfinkel A, Cooper CB.

Med Sci Sports Exerc. 2014 Jun;46(6):1057-66. doi: 10.1249/MSS.0000000000000201.

20.

The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample.

Nielsen S, Hillhouse M, Weiss RD, Mooney L, Sharpe Potter J, Lee J, Gourevitch MN, Ling W.

Am J Addict. 2014 Jul-Aug;23(4):343-8. doi: 10.1111/j.1521-0391.2013.12105.x. Epub 2013 Sep 24.

Supplemental Content

Loading ...
Support Center